---
title: "Prevail DCB gains expanded CE mark indications"
date: "2025-05-22T14:43:17.000Z"
publishedDate: "22 mai 2025"
summary: "Medtronic has received CE mark approval for several expanded indications for the treatment of coronary artery disease (CAD) with the Prevail paclitaxel-coated percutaneous transluminal coronary angioplasty (PTCA) balloon catheter, or drug-coated balloon (DCB). The Prevail DCB now has the broadest range of CE Mark indications including bifurcation and is the only DCB indicated for treatment [&#8230;] The post Prevail DCB gains expanded CE mark indications appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/prevail-dcb-gains-expanded-ce-mark-indications/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-05-22-prevail-dcb-gains-expanded-ce-mark-indications"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/10/balloon-1600x1000-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/prevail-dcb-gains-expanded-ce-mark-indications/"
---

![Prevail DCB gains expanded CE mark indications](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/10/balloon-1600x1000-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/prevail-dcb-gains-expanded-ce-mark-indications/*

## L’essentiel

Medtronic has received CE mark approval for several expanded indications for the treatment of coronary artery disease (CAD) with the Prevail paclitaxel-coated percutaneous transluminal coronary angioplasty (PTCA) balloon catheter, or drug-coated balloon (DCB). The Prevail DCB now has the broadest range of CE Mark indications including bifurcation and is the only DCB indicated for treatment [&#8230;] The post Prevail DCB gains expanded CE mark indications appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/prevail-dcb-gains-expanded-ce-mark-indications/
